Ticker: BBIO

Company: BridgeBio Pharma, Inc.

Person: Maricel Apuli, officer

Transaction date: April 30, 2026

Reporting date: May 4, 2026

Average share price: 71.58

Sold 2000.0 shares for 143160.0